A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer VS. conventionally fractionated 60 GY: Results of a randomized equivalence study

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 1, 2000, Pages 95-103

  Nestle, Ursula ^a   Nieder, Carsten ^b   Walter, Karin ^a   Abel, Ulrich ^c   Ukena, Dieter ^a   Sybrecht, Gerhard W ^a   Schnabel, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Conventional irradiation; Lung cancer; Non small cell; Palliative irradiation; Radiotherapy

Indexed keywords

ACCELERATION; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; ESOPHAGITIS; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; REGRESSION ANALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 0034255783     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00607-6     Document Type: Article

References (31)

1. Non-small cell lung cancer collaborative group, Stewart LA. Chemotherapy in NSCLC: A meta-analysis using updated data from 52 randomized clinical trials. BMJ 1995;311:899-909.
2. Marino P., Praetoiani A., Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIA and IIIB nonsmall cell lung cancer. Cancer. 76:(4):1995;593-601.
3. Bunn P.A., Vokes E., Langer C.A., et al. An update on North-American randomized studies in non-small cell lung cancer. Semin Oncol. 25:(Suppl. 9):1998;2-10.
4. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79. 2 Gy: Possible survival benefit with 69.6 Gy in favourable patients with RTOG stage III non-small-cell lung carcinoma: Report of the RTOG 83-11. J Clin Oncol. 8:1990;1543-1555.
5. Baumann M., Herrmann T., Matthiesen W., et al. CHARTWEL-Bronchus (ARO 97-1) Eine randomisiert multizentrische Studie zum Vergleich einer konventionell fraktionierten Strahlentherapie mit CHARTWEL-Bestrahlung bei inoperablen nichtkleinzelligen Bronchialkarzinomen. Strahlenther Onkol. 173:(12):1997;663-667.
6. Saunders M., Dische S., Barrett A., et al. Continous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer A randomized multicentre trial . Lancet. 350:1997;161-165.
7. Saunders M.I., Rojas A., Lyn B.E., et al. Experience with dose escalation using CHARTWEL (continous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer. Br J Cancer. 78:(10):1998;1323-1328.
8. Armstrong J., Raben A., Zelefsky M., et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 44:(1):1997;17-22.
9. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 37:(5):1997;1079-1085.
10. Sibley G.S., Mundt A.J., Shapiro C., et al. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int J Radiat Oncol Biol Phys. 33:(5):1995;1001-1007.
11. MRC lung cancer working party, Bleehen NM, Girling DJ, Fayers PM; et al. Inoperable non-small-cell-lung cancer (NSCLC): A medical research council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer 1991;63:265-270.
12. MRC lung cancer working party, Bleehen NM, Girling DJ, Machin D; et al. A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992;65:934-941.
13. Abratt R.P., Shepherd L.J., Mameena Salton D.G. Palliative radiation for stage 3 non-small cell lung cancer - A prospective study of two moderately high dose regimens. Lung Cancer. 13:1995;137-143.
14. Appold S., Baumann M., Neidt F., et al. Ergebnisse der Bestrahlung inoperabler nichtkleinzelliger Bronchialkatzinome im Stadium III mit 25 Gy in fünf Fraktionen. Strahlenther Onkol. 175:(6):1999;267-270.
15. Thatcher N., Niven R.M., Anderson H. Aggressive vs. nonaggressive therapy for metastatis NSCLC. Chest. 109:(Suppl.):1996;87S-92S.
16. MRC lung cancer working party, Macbeth F, Bolger JJ, Hopwood P; et al. Randomized trial of palliative two-fraction vs. more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol 1996;8:167-175.
17. Emami B, Perez CA. Lung. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 2nd ed. Philadelphia: Lipincott Company; 1992. p. 806-836.
18. Berberich W, Bier B, Schnabel K; et al. Hyperfractionated irradiation of non-small cell bronchial cancer. Final results of a phase II study. Strahlenther Onkol 1993;169(8):469-175.
19. Wilhelm R., Kovacs G., Heinrichsohn D., et al. Survival of exclusively irradiated patients with NSCLC. Significance of pretherapeutic hemoglobin level. Strahlenther Onkol. 174:(3):1998;128-132.
20. Nestle U., Nieder C., Abel U., et al. A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC). Radiother Oncol. 38:(3):1996;195-203.
21. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley; 1980.
22. Cox D.R. Regression models and life tables (with discussion). J Stat Soc [B]. 34:1972;187-220.
23. Saunders M., Dische S. Continous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys. 19:1990;1211-1215.
24. The Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the non-surgical management of lung cancer. Section 11: Radical therapy for stage IIIA and IIIB non-small cell lung cancer. Clin Oncol 1999;11(Suppl):S29-32.
25. Ukena D., Leutz M., Huwer H., et al. Induction chemotherapy with paclitaxel and carboplatin in locally advanced stage IIIA/IIIB non-small cell lung cancer (NSCLC) (Abstr. ). Lung Cancer. 18:(Suppl. 1):1997;60.
26. Paesmans M., Sculier J.P., Libert P., et al. Prognositc factors for survival in advanced non-small cell lung cancer Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients . J Clin Oncol. 13:(5):1995;1221-1230.
27. Kreisman H., Lisbona A., Olson L., et al. Effect of radiologic stage III substageon nonsurgical therapy of non-small cell lung cancer. Cancer. 72:(5):1993;1588-1596.
28. Arriagada R. Current strategies for radiation therapy in non-small cell lung cancer. Chest. 112:(4):1997;209S.
29. Nestle U., Nieder C., Walter K., et al. Strahlentherapie des nicht-kleinzelligen Bronchialkarzinoms in Abhängigkeit vom Metastasierungstyp (Abstr. ). Fortschr Geb Rontgenstr Nuklearmed Erganzungsbd. 164:(Suppl. 1):1996;S69.
30. Perez C.A., Pajak T.F., Rubin P., et al. Long time observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy Report by the RTOG . Cancer. 59:1987;1874-1881.
31. Gregor A., Macbeth F.R., Paul J. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer A randomized trial . J Natl Cancer Inst. 85:1993;997-999.